Rchr
J-GLOBAL ID：201801006833433268   Update date: May. 13, 2024

Namisaki Tadashi

Namisaki Tadashi
Affiliation and department：
-

About -


Research field  (1)： Gastroenterology
Research keywords  (4)： 肝硬変 ,  Non-alcoholic steatohepatitis ,  liver fibrosis ,  liver cancer
Research theme for competitive and other funds  (7)：
  • 2022 - 2025 血液凝固制御因子ADAMTS13による急性肝不全新規治療法とバイオマーカーの開発
  • 2021 - 2024 Novel Liver Cirrhosis Treatment by Drug Repositioning and Leaky Gut Control
  • 2017 - 2020 Therapeutic effect of Equol on gut microbiome - mediated NASH progression
  • 2014 - 2017 Establishment of new treatment targeting lifestyle diseases and coagulation fibrinolytic system related to the development of NASH
  • 2015 - 2017 Identification of novel treatment and biomarkers based on pharmacokinetics in patients with hepatocellular carcinoma
Show all
Papers (272)：
  • Jun-Ichi Hanatani, Koh Kitagawa, Fumimasa Tomooka, Shohei Asada, Akira Mitoro, Yukihisa Fujinaga, Norihisa Nishimura, Shinya Sato, Akihiko Shibamoto, Yuki Fujimoto, et al. Impact of the COVID-19 pandemic on the treatment of acute cholangitis caused by choledocholithiasis: A single-center retrospective study in Japan. DEN open. 2025. 5. 1. e371
  • Tetsuya Tachiiri, Kiyoyuki Minamiguchi, Ryosuke Taiji, Takeshi Sato, Shohei Toyoda, Takeshi Matsumoto, Yuto Chanoki, Hideki Kunichika, Satoshi Yamauchi, Sho Shimizu, et al. Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma. Cancers. 2024. 16. 9
  • Takahiro Kubo, Norihisa Nishimura, Kosuke Kaji, Fumimasa Tomooka, Akihiko Shibamoto, Satoshi Iwai, Junya Suzuki, Hideto Kawaratani, Tadashi Namisaki, Takemi Akahane, et al. Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment. International journal of molecular sciences. 2024. 25. 8
  • Tadashi Namisaki, Shinya Sato, Hitoshi Yoshiji. Role of combined aerobic and resistance exercise in liver cirrhosis. Journal of gastroenterology. 2024. 59. 4. 359-360
  • Tadashi Namisaki. Noninvasive assessment of portal hypertension based on the Baveno VII criteria. Hepatology research : the official journal of the Japan Society of Hepatology. 2024. 54. 4. 323-325
ｍore...
MISC (793)：
  • 浪崎 正, 吉治 仁志. アルコールと脂肪性肝疾患の診断と治療-Clinical diagnosis and treatment of alcoholic liver disease and steatotic liver disease-特集 慢性肝臓病の克服を目指して. 日本内科学会雑誌. 2024. 113. 1. 24-31
  • 浪崎正, 吉治仁志. Overcoming Chronic Liver Disease. Topics: III. Clinical diagnosis and treatment of alcoholic liver disease and steatotic liver disease. 日本内科学会雑誌. 2024. 113. 1
  • 浪崎正, 竹田惣一, 辻裕樹, 鍛治孝祐, 吉治仁志. 進行肝細胞癌に対する腸管透過性を指標としたアテゾリブマブ+ベバシズマブ併用療法の治療効果予測. 日本肝がん分子標的治療研究会プログラム・抄録集. 2024. 29th
  • 浪崎正, 吉治仁志. Psychiatric-Medical Cooperation In Alcoholism General Introduction from the past to the present. Frontiers in Alcoholism. 2024. 12. 1
  • 米田 健人, 尾山 雅文, 藤永 幸久, 浅田 翔平, 浪崎 正, 美登路 昭. ミニトマトの嵌頓を認めた小児食道異物の1例. 日本消化器内視鏡学会近畿支部例会プログラム・抄録集. 2023. 111回. 81-81
ｍore...
Patents (2)：
Books (3)：
  • 目覚ましく治療効果を発揮するC型肝炎治療
    メジカルビュー社 2017
  • UDCAとアンギオテンシンII受容体拮抗薬はNASH治療へ展開可能か?
    アークメディア 2016
  • 消化器研修ノート 改訂第2版
    診断と治療社 2016
Education (4)：
  • 2006 - 現在 Nara Medical University
  • 2002 - 2006 Nara Medical University Graduate School of Medical Science Course
  • 1997 - 2002 Nara Medical University
  • 1991 - 1997 Osaka Medical College
Work history (7)：
  • 2019/10 - 現在 奈良県立医科大学 消化器代内科 講師
  • 2016/04 - 2019/09 Nara Medical University
  • 2015/10 - 2016/03 奈良県立医大 内科学第三講座 学内講師
  • 2013/04 - 2015/09 Nara Medical University
  • 2012/01 - 2013/03 Nara Medical University
Show all
Committee career (5)：
  • 2018/12 - 現在 日本消化器病学会評議員
  • 2017/04 - 現在 日本内科学会 近畿支部評議員
  • 2015/12 - 現在 日本肝臓学西部会評議員
  • 2014/01 - 現在 日本消化器病学会支部評議員
  • 2020/04 - 2022/03 日本肝臓学会 学会評議員
Awards (4)：
  • 2009 - Asian Pacific Association for the Study of the Liver (APASL) Conference Presidential Poster of Distinction
  • 2007 - Nara Medical Association Academic Award
  • 2005/11 - Annual Meeting of American Association for the Study liver Diseases Presidential Poster of Distinction
  • 2005/10 - 日本肝臓学会 ポスターセッション優秀演題賞
Association Membership(s) (4)：
THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY ,  JAPANESE SOCIETY OF GASTROENTEROLOGY ,  THE JAPAN SOCIETY OF HEPATOLOGY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM